Building a Pipeline of Therapeutics that Target Diseases of Aging @LifespanIO
Building a Pipeline of Therapeutics that Target Diseases of Aging  @LifespanIO
Uploaded July 2023 | Updated November 2026, 1 day ago
At Ending Age-Related Diseases 2022, Hanadie Yousef of Juvena Therapeutics led a discussion panel with Ashley Zehnder of Fauna Bio, Glenn Markov of Rejuvenation Technologies, and Maddalena Adorno of Dorian Therapeutics. The purpose of this panel was to discuss a full developmental pipeline with which to develop prospective drugs that directly target the diseases and hallmarks of aging.

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io

HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#longevity #pharma #development
Building a Pipeline of Therapeutics that Target Diseases of AgingRejuvenating the Heart with Extracellular Vesicles from Stem CellsSavva Kerdemelidis at EARD 2022: Using Financial Innovation to Incentivize Longevity MedicineEpigenetics Clocks to Identify Novel Ani-Aging Interventions: Dr. Steve Horvath at EARD 2023Exercise Lowers SASP Levels In Seniors | Lifespan News ExtraBuilding the physical Infrastructure of Decentralized Science: Harry Gandhi at EARD 2023A Better Senescence Biomarker | Lifespan News ExtraHealthspan vs. Lifespan - Are We Asking the Wrong Question? | Longevity Biomarker Summit PanelLoss of resilience may limit human lifespan | Lifespan News ExtraModifying Longevity In HumansCan Crypto Save Your Life? w/ Qiao Wang of DeFi Alliance, Marc P. Bernegger of Maximon & Lifespan.ioSelf-sovereign, Verifiable, Compliant Data and the Role of NFTs in DeSci - Omar ElNaggar: EARD2023
Lifespan Research Institute |

Building a Pipeline of Therapeutics that Target Diseases of Aging

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER